These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25201005)

  • 21. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
    Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
    de Pádua Covas Lage LA; Dos Santos FFC; Levy D; Moreira FR; Couto SCF; Culler HF; de Oliveira Costa R; Rocha V; Pereira J
    BMC Cancer; 2020 Aug; 20(1):717. PubMed ID: 32746790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia.
    Abramson JS; Chatterji M; Rahemtullah A
    N Engl J Med; 2008 Dec; 359(25):2707-18. PubMed ID: 19092156
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinicopathological features of splenic tumours of lymphoid tissue.
    Chen DB; Shen DH; Yang SM; Fang XZ
    Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
    Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
    Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
    Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H; Jung B; Tonassi L; Hackenberg U; Plum N; Josten KM; Kirchmaier CM; Frickhofen N
    Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma.
    Olszewski AJ
    Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.
    Komeno Y; Shibuya N; Uryu H; Yamada H; Toda T; Shibasaki M; Kunishima S; Iihara K; Ryu T
    Intern Med; 2017; 56(5):557-562. PubMed ID: 28250305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count].
    Yang SM; Jiang Q; Jiang B; Chen DB; Wang J; Jiang H; Lu J; Lu XJ; Bao L; Shi HX; Liu YR; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):87-94. PubMed ID: 23484698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
    Castelli R; Bergamaschini L; Deliliers GL
    Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-of-the-art therapeutics: marginal-zone lymphoma.
    Bertoni F; Zucca E
    J Clin Oncol; 2005 Sep; 23(26):6415-20. PubMed ID: 16155028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
    Vinholt PJ; Nybo M
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
    Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
    Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Kalpadakis C; Pangalis GA; Dimopoulou MN; Vassilakopoulos TP; Kyrtsonis MC; Korkolopoulou P; Kontopidou FN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Tsaftaridis P; Plata E; Angelopoulou MK
    Hematol Oncol; 2007 Sep; 25(3):127-31. PubMed ID: 17514771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.